Literature DB >> 20093369

Physical interaction of Jab1 with human serotonin 6 G-protein-coupled receptor and their possible roles in cell survival.

Hyung-Mun Yun1, Ja-Hyun Baik, Insug Kang, Changbae Jin, Hyewhon Rhim.   

Abstract

The 5-HT(6) receptor (5-HT(6)R) is one of the most recently cloned serotonin receptors, and it plays important roles in Alzheimer disease, depression, and learning and memory disorders. However, unlike the other serotonin receptors, the cellular mechanisms of 5-HT(6)R are poorly elucidated relative to its significance in human brain diseases. Here, using a yeast two-hybrid assay, we found that the human 5-HT(6)R interacts with Jun activation domain-binding protein-1 (Jab1). We also confirmed a physical interaction between 5-HT(6)R and Jab1 using glutathione S-transferase pulldown, fluorescence resonance energy transfer, co-immunoprecipitation, and immunocyto(histo)chemistry assays. The manipulation of Jab1 expression using Jab1 small interference RNA decreased 5-HT(6)R-mediated activity and cell membrane expression of 5-HT(6)R, whereas overexpression of Jab1 produced no significant effect. In addition, we demonstrated that the activation of 5-HT(6)R induced the translocation of Jab1 into the nucleus and increased c-Jun phosphorylation and the interaction between Jab1 and c-Jun. Furthermore, we found that 5-HT(6)R and Jab1 were up-regulated in middle cerebral artery occlusion-induced focal cerebral ischemic rats and in cultured cells exposed to hypoxic insults, suggesting possible protective roles for 5-HT(6)R and Jab1. These findings suggest that Jab1 provides a novel signal transduction pathway for 5-HT(6)R and may play an important role in 5-HT(6)R-mediated behavior changes in the brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093369      PMCID: PMC2843165          DOI: 10.1074/jbc.M109.068759

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

Review 1.  5-ht6 receptors as emerging targets for drug discovery.

Authors:  T A Branchek; T P Blackburn
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

2.  Jab1 mediates cytoplasmic localization and degradation of West Nile virus capsid protein.

Authors:  Wonkyung Oh; Mi-Ran Yang; Eun-Woo Lee; Ki-Moon Park; Suhkneung Pyo; Joo-Sung Yang; Han-Woong Lee; Jaewhan Song
Journal:  J Biol Chem       Date:  2006-08-01       Impact factor: 5.157

3.  Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor.

Authors:  R Kohen; M A Metcalf; N Khan; T Druck; K Huebner; J E Lachowicz; H Y Meltzer; D R Sibley; B L Roth; M W Hamblin
Journal:  J Neurochem       Date:  1996-01       Impact factor: 5.372

4.  Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1.

Authors:  K Tomoda; Y Kubota; J Kato
Journal:  Nature       Date:  1999-03-11       Impact factor: 49.962

5.  Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.

Authors:  R Kleemann; A Hausser; G Geiger; R Mischke; A Burger-Kentischer; O Flieger; F J Johannes; T Roger; T Calandra; A Kapurniotu; M Grell; D Finkelmeier; H Brunner; J Bernhagen
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

Review 6.  Jab1 as a mediator of nuclear export and cytoplasmic degradation of p53.

Authors:  Eun-Woo Lee; Wonkyung Oh; Jaewhan Song
Journal:  Mol Cells       Date:  2006-10-31       Impact factor: 5.034

7.  Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.

Authors:  Chae Young Hwang; Yeung Sook Ryu; Mi-Sun Chung; Kwang Dong Kim; Sung Sup Park; Suhn-Kee Chae; Ho Zoon Chae; Ki-Sun Kwon
Journal:  Oncogene       Date:  2004-11-25       Impact factor: 9.867

8.  The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats.

Authors:  Andrew G Foley; Keith J Murphy; Warren D Hirst; Helen C Gallagher; Jim J Hagan; Neil Upton; Frank S Walsh; Ciaran M Regan
Journal:  Neuropsychopharmacology       Date:  2004-01       Impact factor: 7.853

9.  Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma.

Authors:  Jihyun Ahn; Soon Auck Hong; Seung-Eun Lee; Jaetaek Kim; Yeon Sahng Oh; Sung Jun Park; Yun Jae Chung
Journal:  Endocr J       Date:  2009-05-20       Impact factor: 2.349

10.  Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity.

Authors:  E Bianchi; S Denti; A Granata; G Bossi; J Geginat; A Villa; L Rogge; R Pardi
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

View more
  21 in total

1.  Role of p97/Valosin-containing protein (VCP) and Jab1/CSN5 in testicular ischaemia-reperfusion injury.

Authors:  Sevil Cayli; Seda Ocakli; Ufuk Senel; Nilnur Eyerci; Tuncay Delibasi
Journal:  J Mol Histol       Date:  2016-01-11       Impact factor: 2.611

2.  Restoration of Physiological Expression of 5-HT6 Receptor into the Primary Cilia of Null Mutant Neurons Lengthens Both Primary Cilia and Dendrites.

Authors:  Atom J Lesiak; Matthew Brodsky; Nathalie Cohenca; Alexandra G Croicu; John F Neumaier
Journal:  Mol Pharmacol       Date:  2018-04-20       Impact factor: 4.436

3.  Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity.

Authors:  Wissem Deraredj Nadim; Séverine Chaumont-Dubel; Fahima Madouri; Laetitia Cobret; Marie-Ludivine De Tauzia; Pawel Zajdel; Hélène Bénédetti; Philippe Marin; Séverine Morisset-Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-10       Impact factor: 11.205

4.  Over-expression of 5-HT6 Receptor and Activated Jab-1/p-c-Jun Play Important Roles in Pilocarpine-Induced Seizures and Learning-Memory Impairment.

Authors:  Changyun Liu; Yuxing Wen; Huapin Huang; Wanhui Lin; Mingzhu Huang; Rong Lin; Ying Ma
Journal:  J Mol Neurosci       Date:  2019-01-29       Impact factor: 3.444

Review 5.  Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status.

Authors:  Hilda Ferrero; Maite Solas; Paul T Francis; Maria J Ramirez
Journal:  CNS Drugs       Date:  2017-01       Impact factor: 5.749

6.  JAB1/CSN5: a new player in cell cycle control and cancer.

Authors:  Terry J Shackleford; Francois X Claret
Journal:  Cell Div       Date:  2010-10-18       Impact factor: 5.130

7.  COPS5 (Jab1) protein increases β site processing of amyloid precursor protein and amyloid β peptide generation by stabilizing RanBP9 protein levels.

Authors:  Hongjie Wang; Debleena Dey; Ivan Carrera; Dmitriy Minond; Elisabetta Bianchi; Shaohua Xu; Madepalli K Lakshmana
Journal:  J Biol Chem       Date:  2013-08-07       Impact factor: 5.157

8.  5-HT(6) receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms.

Authors:  S Woods; N N Clarke; R Layfield; K C F Fone
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

9.  The serotonin-6 receptor as a novel therapeutic target.

Authors:  Hyung-Mun Yun; Hyewhon Rhim
Journal:  Exp Neurobiol       Date:  2011-12-29       Impact factor: 3.261

10.  Excess of serotonin affects neocortical pyramidal neuron migration.

Authors:  O Riccio; M Jacobshagen; B Golding; L Vutskits; D Jabaudon; J P Hornung; A G Dayer
Journal:  Transl Psychiatry       Date:  2011-10-11       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.